Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer

Key Points

The analysis reveals significant variation in antiemetic effectiveness across different CINV phases, impacting patients' experiences.
Data from a homogeneous cohort underscores the need for tailored prophylactic strategies for symptom management.
Assessment of real-world evidence highlights a crucial connection between antiemetic use and quality of life during chemotherapy.
Optimizing strategies for nausea control may enhance overall patient well-being, indicating a need for further phase-specific guidelines.

Abstract

This real-world analysis demonstrates that antiemetic effectiveness varies by CINV phase, even within a relatively homogeneous, high-risk patient cohort. The results highlight the importance of phase-tailored prophylactic strategies to optimize symptom control and improve patient quality of life in highly emetogenic chemotherapy settings.

Bookmark

View Full Paper

Bookmark

View Full Paper

Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer

Key Points

Abstract

Cite This Study

Also Consider

Also Consider